Prescient Therapeutics Completes First Site Initiation Visit for Cancer Treatment Candidate Trial; Shares Up 7%

MT NewswiresMar 25 22:52 ET

Prescient Therapeutics Appoints New Chief Medical Officer to Drive Cancer Therapy Innovations

TipRanksMar 24 07:48 ET

Prescient Therapeutics to Present PTX-100 Clinical Data at International T-cell Lymphoma Forum | ASX:PTX, OTC:PSTTF

Proactive InvestorsMar 20 20:41 ET

Prescient Therapeutics Appoints Chair; Shares Fall 7%

MT NewswiresMar 10 21:22 ET

Prescient Therapeutics Embarks on Board Chair Transition Process as Chair Retires | ASX:PTX, OTC:PSTTF

Proactive InvestorsMar 10 20:49 ET

Prescient Therapeutics Ltd: Appendix 4D and Half Year Financial Report

ASXFeb 20 17:56 ET · Announcements